Today, Co-CEO Dr. Jason Auerbach announces Mark Censoprano as the new Co-Chief Executive Officer at MAX Surgical Specialty Management, effective immediately. As Co-CEO, Mark will work alongside Dr. Auerbach to lead MAX’s growth strategy and executive team.
Mark’s arrival will accelerate the already exceptional growth that MAX SSM has enjoyed since its inception. His wealth of knowledge and proven track record of success, coupled with his leadership within two of Fortune's Top 100 Best Companies to Work For, will undoubtedly bolster the practices’ and MAX’s already outstanding reputation. As CEO, President, and CMO/COO, Mark grew Guardian Dentistry Partners into one of the most respected organizations in the industry, with 170 locations across 11 states. Mark’s experience as CMO at Aspen Dental earlier in his career, where he led transformative brand initiatives, which contributed to the doubling of sales and earnings during his tenure.
“In the short time I have known him, Mark has already proven to be an insightful, cooperative, and motivated partner with great energy and a genuinely collaborative demeanor,” says Dr. Auerbach. “That’s what set him apart, and ultimately, that’s what I believe will complement an already amazing team at MAX and our family of practices. This is a new chapter, having Mark join MAX. I am confident that his strategic vision, leadership, and industry-specific expertise will be invaluable as we continue to grow and achieve our goals while never losing focus of what got us here in the first place: our absolute dedication to our patients, to our referring doctors, and our surgeons, the heartbeat of our organization.”
Together with leadership from Dr. Auerbach and Mark Censoprano, MAX will continue to build upon the organization’s promise to reshape the future of oral & maxillofacial surgical care. The MAX team is excited for all that is to come under Mark’s guidance. To learn more about Mark, you can find him at https://www.linkedin.com/in/mark-censoprano/.
MAX is grateful to Interim Co-CEO Jeff Ward for his unwavering support in leading the MAX executive team while balancing the significant responsibilities associated with running MedEquity Capital. Mark's addition to MAX will allow Jeff to refocus his efforts and contributions to MAX as Executive Chairman of the Board of Directors.
